Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Path Holdings, Inc. - Common Stock
(NQ:
BPTH
)
0.2100
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Path Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 18, 2024
Via
Benzinga
Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients
April 18, 2024
BP1002 Offers Unique Opportunity for Venetoclax-Resistant AML Patients Utilizing RNAi to Limit AML Cell’s Ability to Produce Cancer Enabling Bcl-2 Protein
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Expands Global Patent Portfolio
April 15, 2024
Builds on Global Intellectual Property Portfolio to Protect DNAbilize® Platform
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings's Earnings: A Preview
March 07, 2024
Via
Benzinga
Bio-Path Hldgs: Q3 Earnings Insights
November 15, 2023
Via
Benzinga
Preview: Bio-Path Holdings's Earnings
November 14, 2023
Via
Benzinga
Bio-Path Holdings Provides 2024 Clinical and Operational Update
April 02, 2024
Clinical Advances Across Multiple Programs with Several Milestones
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q4 23
March 27, 2024
Dallas, Texas--(Newsfile Corp. - March 27, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate...
Via
Newsfile
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 13, 2024
Pre-market stock movers are a great way to start the day with all of the hottest news worth reading about on Wednesday morning!
Via
InvestorPlace
Why Bio-Path Holdings Shares Are Falling Today
March 08, 2024
Bio-Path reported a net loss of $33.63 per share for the year ended Dec. 31, 2023, lower than $38.12 per share in the year-ago period.
Via
Benzinga
Bio-Path Holdings Reports Full Year 2023 Financial Results
March 08, 2024
Conference Call to be Held Today at 8:30 A.M. ET
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Earnings Scheduled For March 8, 2024
March 08, 2024
Companies Reporting Before The Bell • Algonquin Power (NYSE:AQN) is likely to report quarterly earnings at $0.14 per share on revenue of $743.00 million.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 07, 2024
Via
Benzinga
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
March 01, 2024
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Announces 1-for-20 Reverse Stock Split
February 21, 2024
Shares of Common Stock Will Begin Trading on a Split-Adjusted Basis on February 23, 2024
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 10, 2024
Via
Benzinga
Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients
January 10, 2024
Targeting Bcl-2 Protein Offers Potential Treatment for Patients Who Have Failed or Relapsed from Venetoclax-Based Frontline Therapy
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 14, 2023
Via
Benzinga
Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia
December 14, 2023
BP1002 Offers Unique Opportunity for Venetoclax-Resistant Patients by Utilizing RNAi to Limit Cells’ Ability to Produce Bcl-2 Protein
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Why UP Fintech Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
November 27, 2023
Shares of UP Fintech Holding Limited (NASDAQ: TIGR) surged in pre-market trading after the company results for the third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
November 24, 2023
Via
Benzinga
Bio-Path Holdings Reports Third Quarter 2023 Financial Results
November 15, 2023
Conference Call to be Held Today at 8:30 A.M. ET
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 08, 2023
Via
Benzinga
Bio-Path Holdings to Announce Third Quarter 2023 Financial Results on November 15, 2023
November 08, 2023
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings to Host Virtual Key Opinion Leader Event to Discuss Prexigebersen and Advances in the Treatment Landscape for Acute Myeloid Leukemia
October 24, 2023
Conference call to be held on Monday, October 30, 2023 at 9:00 a.m. ET
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
October 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
October 18, 2023
Via
Benzinga
Why Talaris Therapeutics Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
October 18, 2023
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed for Chapter 7 bankruptcy in the U.S. Bankruptcy Court...
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 17, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Via
Benzinga
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 16, 2023
Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.